Literature DB >> 17443494

Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.

Michael P Endsley1, Nitin Aggarwal, Marilyn A Isbell, Craig E Wheelock, Bruce D Hammock, John R Falck, William B Campbell, Kasem Nithipatikom.   

Abstract

Endogenous 2-arachidonoylglycerol (2-AG) is antiinvasive in androgen-independent prostate carcinoma (PC-3) cells. Invasion of PC-3 cells is also inhibited by exogenously added noladin ether, a non-hydrolyzable analog of 2-AG. In contrast, exogenous 2-AG has the opposite effect. Cell invasion significantly increased with high concentrations of exogenous 2-AG. In PC-3 cells, arachidonic acid (AA) and 12-hydroxyeicosatetraenoic acid (12-HETE) concentrations increased along with exogenously added 2-AG, and 12-HETE concentrations increased with exogenously added AA. Invasion of PC-3 cells also increased with exogenously added AA and 12(S)-HETE but not 12(R)-HETE. The exogenous 2-AG-induced invasion of PC-3 cells was inhibited by 3-octylthio-1,1,1-trifluoropropan-2-one (OTFP, an inhibitor of 2-AG hydrolysis) and baicalein (a 12-LO inhibitor). Western blot and RT-PCR analyses indicated expression of 12-HETE producing lipoxygenases (LOs), platelet-type 12-LO (P-12-LO) and leukocyte-type 12-LO (L-12-LO), in PC-3 cells. These results suggest that exogenous 2-AG induced, rather inhibited, cell invasion because of its rapid hydrolysis to free AA, and further metabolism by 12-LO of AA to 12(S)-HETE, a promoter of PC cell invasion. The results also suggest that PC-3 cells and human prostate stromal (WPMY-1) cells released free AA, 2-AG, and 12-HETE. In the microenvironment of the PC cells, this may contribute to the cell invasion. The 2-AG hydrolysis and concentration of 2-AG in microenvironment are critical for PC cell's fate. Therefore, inhibitors of 2-AG hydrolysis could potentially serve as therapeutic agents for the treatment of prostate cancer. (c) 2007 Wiley-Liss, Inc. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443494      PMCID: PMC2565646          DOI: 10.1002/ijc.22761

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

Review 1.  12-Lipoxygenase: classification, possible therapeutic benefits from inhibition, and inhibitors.

Authors:  L A Dailey; P Imming
Journal:  Curr Med Chem       Date:  1999-05       Impact factor: 4.530

2.  Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.

Authors:  S K Goparaju; N Ueda; K Taniguchi; S Yamamoto
Journal:  Biochem Pharmacol       Date:  1999-02-15       Impact factor: 5.858

3.  Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase.

Authors:  L Y Chau; H H Tai
Journal:  Biochem Biophys Res Commun       Date:  1981-06       Impact factor: 3.575

4.  Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages.

Authors:  V Di Marzo; T Bisogno; L De Petrocellis; D Melck; P Orlando; J A Wagner; G Kunos
Journal:  Eur J Biochem       Date:  1999-08

5.  2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.

Authors:  Kasem Nithipatikom; Michael P Endsley; Marilyn A Isbell; John R Falck; Yoshiki Iwamoto; Cecilia J Hillard; William B Campbell
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

6.  Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.

Authors:  Kathryn M Gauthier; David V Baewer; Sarah Hittner; Cecilia J Hillard; Kasem Nithipatikom; D Sudarshan Reddy; J R Falck; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-04       Impact factor: 4.733

7.  Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.

Authors:  K Varga; J A Wagner; D T Bridgen; G Kunos
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

8.  Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase.

Authors:  Daotai Nie; Jeffrey Nemeth; Yan Qiao; Alex Zacharek; Li Li; Kenny Hanna; Keqin Tang; Gilda G Hillman; Michael L Cher; David J Grignon; Kenneth V Honn
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.

Authors:  Maurizio Bifulco; Chiara Laezza; Marta Valenti; Alessia Ligresti; Giuseppe Portella; Vincenzo DI Marzo
Journal:  FASEB J       Date:  2004-08-02       Impact factor: 5.191

10.  Diglyceride/monoglyceride lipases pathway is not essential for arachidonate release in thrombin-activated human platelets.

Authors:  L Y Chau; H H Tai
Journal:  Biochem Biophys Res Commun       Date:  1983-05-31       Impact factor: 3.575

View more
  26 in total

Review 1.  Endocannabinoids and immune regulation.

Authors:  Rupal Pandey; Khalida Mousawy; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Pharmacol Res       Date:  2009-04-07       Impact factor: 7.658

2.  A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Kasem Nithipatikom; Michael P Endsley; Adam W Pfeiffer; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2014-06-23       Impact factor: 5.922

3.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

Review 4.  The endocannabinoid system in prostate cancer.

Authors:  Inés Díaz-Laviada
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

Review 5.  The endocannabinoid system and cancer: therapeutic implication.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

6.  Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries.

Authors:  Kathryn M Gauthier; Daniel H Goldman; Nitin T Aggarwal; Yuttana Chawengsub; J R Falck; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-30       Impact factor: 4.733

7.  Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Michael P Endsley; Jeffrey E Woodliff; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-12-15       Impact factor: 3.072

8.  Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Ana Doris Gomez-Granados; Alan T Tang; Adam W Pfeiffer; Carol L Williams; William B Campbell
Journal:  Endocrinology       Date:  2011-11-15       Impact factor: 4.736

Review 9.  Insights into the effects of the endocannabinoid system in cancer: a review.

Authors:  Ana Isabel Fraguas-Sánchez; Cristina Martín-Sabroso; Ana Isabel Torres-Suárez
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

10.  Expression and function of fatty acid amide hydrolase in prostate cancer.

Authors:  Michael P Endsley; Rebecca Thill; Iffat Choudhry; Carol L Williams; Andre Kajdacsy-Balla; William B Campbell; Kasem Nithipatikom
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.